MedTrace Logo

Isometric and Isotonic Hand Strengthening in Competitive Female Badminton Athletes

NCT07438522 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2026-02-27

No results posted yet for this study

Summary

This randomized clinical trial aims to determine the effects of targeted isometric and isotonic hand strengthening exercises on hand function, dexterity, grip strength and grip endurance in competitive female badminton athletes aged 18-30 years. Participants will be randomly allocated into two groups receiving either isometric or isotonic hand strengthening exercise programs performed three times per week for six weeks. Outcome measures will be assessed at baseline, 3rd week and 6th week using Michigan Hand Outcomes Questionnaire (MHQ), Purdue Pegboard Test or Nine-Hole Peg Test, Hand Dynamometer Test and Sustained Grip Test.

Conditions

  • Athletic Performance and Injury Risk

Interventions

OTHER

Isometric hand strengthening program

Participants in this group will receive a structured targeted isometric hand strengthening program performed three sessions per week for six weeks

OTHER

Isotonic hand strengthening program

Participants in this group will receive a structured isotonic hand strengthening program performed three sessions per week for six weeks

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • Danish Hassan, PhD · Riphah International University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-12-01
Primary Completion
2026-08-01
Completion
2026-09-01

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07438522 on ClinicalTrials.gov